ClinicalTrials.Veeva

Menu

Follow up of Patients After Oral Immunotherapy for Cow's Milk, Eggs and Peanuts (OIT followup)

S

Shamir Medical Center (Assaf-Harofeh)

Status

Unknown

Conditions

Allergy

Treatments

Dietary Supplement: Allergenic food

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Food allergy is a potentially life threatening condition. The current practice consists of elimination diet and injectable epinephrine in case of a reaction.

Recently, oral immunotherapy has emerged as a treatment for food allergy in milk eggs and peanuts.

We conduct an oral immunotherapy program with ~500 patients so far. In this study we intent to follow patients who completed the program and assess their allergy status and quality of life.

Full description

Food allergy is a potentially life threatening condition. The current practice consists of elimination diet and injectable epinephrine in case of a reaction.

Recently, oral immunotherapy (OIT) has emerged as an treatment for food allergy in milk eggs and peanuts. Since 4/2010,a clinical OIT program for milk eggs and peanuts is performed at the Institute fir Allergy Asthma and Immunology at Assaf Harofeh Medical Center with ~500 patients so far. Patients with IgE-mediated food allergy that are >4 years old are eligible.

In this study we intent to follow patients who completed the program. Patients will fill a questionnaire regarding current consumption of the allergenic food, adverse reactions experienced and treatments required including the use of EpiPen. Patients underwent skim prick tests (SPT) for the allergenic food prior to initiation and treatment and will undergo SPT again upon entering the study. Blood tests for IgE, IGG4, basophil activation and cytokines will be obtained.

Patients who are not consuming the allergenic food regularly will undergo an oral food challenge in clinic.

Enrollment

500 estimated patients

Sex

All

Ages

4 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age>4 years old IgE mediated allergy to milk eggs or peanuts Completion of OIT >6 months ago

Exclusion criteria

  • Non approval to participate

Trial design

500 participants in 1 patient group

Completed OIT
Description:
Patients who completed OIT \>6 months prior to enrollment
Treatment:
Dietary Supplement: Allergenic food

Trial contacts and locations

1

Loading...

Central trial contact

Yitzhak Katz, MD; Arnon Elizur

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems